-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Equal-Weight on Amgen, Raises Price Target to $380

Benzinga·08/14/2026 14:17:59
Listen to the news
Barclays analyst Emily Field maintains Amgen (NASDAQ:AMGN) with a Equal-Weight and raises the price target from $360 to $380.